Short Description
Asia-Pacific Lab Automation Market, By Product Type (Equipment, Software & Informatics, Analyzer), Automation Type (Modular Automation, Total Lab Automation), Application (Drug Discovery, Clinical Diagnostics, Genomics Solutions, Proteomics Solutions, Bio Analysis, Protein Engineering, Lyophilization, System Biology, Analytical Chemistry), End Users (Biotechnology & Pharmaceuticals, Hospitals & Laboratories, Research and Academic Institutions, and Others), Countries (China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, New Zealand, Rest of Asia-Pacific) Industry Trends and Forecast to 2029
Market Definition:
Laboratory automation is the combination of automated technologies in the laboratory to enable new and improved processes. It is used as a strategy to research, develop, optimize and capitalize on technologies in the laboratory. It is specially used for automating laboratory processes requiring minimal human input and eliminating human error. Lab automation is used with the aim of providing more efficient testing and diagnostics.
Lab automation enables researchers and technicians to efficiently and effectively produce output in less time, which is expected to drive the lab automation market. Furthermore, the rapid spread of diseases, along with new discoveries in the field of healthcare, ascend the demand for diagnoses and treatments, which is expected to fuel the lab automation market. High government and private funding for research and discovery research and the presence of major market players also contribute to the market growth.
Market Segmentation:
The Asia-Pacific lab automation market is categorized into four notable segments such as product type, automation type, application, and end users.
On the basis of product type, the Asia-Pacific lab automation market is segmented into equipment, software & informatics, and analyzer
On the basis of automation type, the Asia-Pacific lab automation market is segmented into modular automation and total lab automation
On the basis of application, the Asia-Pacific lab automation market is segmented into drug discovery, clinical diagnostics, genomic solutions, proteomic solutions, bio analysis, protein engineering, lyophilization, system biology, analytical chemistry, and others
On the basis of end users, the Asia-Pacific lab automation market is segmented into biotechnology & pharmaceuticals, hospitals & laboratories, research and academic institutions, and others
Market Players
Some of the key market players in the Asia-Pacific lab automation market are listed below:
Danaher
PerkinElmer Inc.
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
QIAGEN
F. Hoffman-La Roche Ltd
Siemens Healthcare GmbH
Abbott
Aurora Biomed Inc.
BD
BIOMRIEUX
Eppendorf SE
LabVantage Solutions Inc.
LabWare
Azenta US Inc.
Hamilton Company
Hudson Robotics
Tecan Trading AG
TABLE OF CONTENTS
1 INTRODUCTION 29
1.1 OBJECTIVES OF THE STUDY 29
1.2 MARKET DEFINITION 29
1.3 OVERVIEW OF THE ASIA PACIFIC LAB AUTOMATION MARKET 29
1.4 LIMITATIONS 31
1.5 MARKETS COVERED 31
2 MARKET SEGMENTATION 33
2.1 MARKETS COVERED 33
2.2 GEOGRAPHICAL SCOPE 34
2.3 YEARS CONSIDERED FOR THE STUDY 35
2.4 CURRENCY AND PRICING 35
2.5 DBMR TRIPOD DATA VALIDATION MODEL 36
2.6 MULTIVARIATE MODELLING 39
2.7 PRODUCT TYPE LIFELINE CURVE 39
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 40
2.9 DBMR MARKET POSITION GRID 41
2.10 MARKET END USER COVERAGE GRID 42
2.11 VENDOR SHARE ANALYSIS 43
2.12 SECONDARY SOURCES 44
2.13 ASSUMPTIONS 44
3 EXECUTIVE SUMMARY 45
4 PREMIUM INSIGHTS 47
4.1 PESTEL ANALYSIS 48
4.2 PORTERS FIVE FORCES 49
5 REGULATION 50
6 MARKET OVERVIEW 52
6.1 DRIVERS 54
6.1.1 INCREASING INVESTMENT & STRATEGIC INITIATIVES BY MARKET PLAYERS 54
6.1.2 GOVERNMENT INITIATIVES TO STRENGTHEN LABORATORY INFRASTRUCTURES 54
6.1.3 GROWING EXPENDITURE ON LAB AUTOMATION TOOLS AND EQUIPMENT 54
6.1.4 REDUCING HUMAN EFFORTS AND ELIMINATING HUMAN ERROR 55
6.2 RESTRAINTS 55
6.2.1 LIMITATION ANALYZING NOVEL COMPLEX PRODUCT 55
6.2.2 HIGH COST FOR INSTALLATION AND SETUP 55
6.2.3 UPGRADATION, MAINTENANCE, AND PERIODICAL CHECKUPS 56
6.3 OPPORTUNITIES 56
6.3.1 RISING HEALTHCARE EXPENDITURE 56
6.3.2 STRATEGIC INITIATIVES BY KEY PLAYERS 57
6.3.3 RISE IN THE NUMBER OF PHARMA COMPANIES 57
6.4 CHALLENGES 58
6.4.1 SLOW ADOPTION OF AUTOMATION AMONG SMALL AND MEDIUM SIZED LABORATORIES 58
6.4.2 LIMITED FEASIBILITY WITH TECHNOLOGY INTEGRATION IN ANALYTICAL LABS 58
7 ASIA PACIFIC LAB AUTOMATION MARKET, BY PRODUCT TYPE 59
7.1 OVERVIEW 60
7.2 EQUIPMENT 63
7.2.1 AUTOMATED WORKSTATIONS 63
7.2.1.1 AUTOMATED LIQUID HANDLING SYSTEMS 63
7.2.1.2 AUTOMATED INTEGRATED WORKSTATIONS 63
7.2.1.3 PIPETTING SYSTEMS 64
7.2.1.4 MICROPLATE WASHERS 64
7.2.1.5 REAGENT DISPENSERS 64
7.2.2 MICROPLATE READERS 64
7.2.2.1 MULTI-MODE MICROPLATE READERS 64
7.2.2.2 SINGLE-MODE MICROPLATE READERS 64
7.2.2.3 AUTOMATED NUCLEIC ACID PURIFICATION SYSTEMS 64
7.2.2.4 AUTOMATED ELISA SYSTEMS 65
7.2.3 OFF-THE-SHELF AUTOMATED WORKCELLS 65
7.2.4 ROBOTIC SYSTEMS 65
7.2.4.1 ROBOTIC ARMS 65
7.2.4.2 TRACK ROBOTS 65
7.2.5 AUTOMATE STORAGE & RETRIEVALS (ASRS) 65
7.2.6 OTHERS 65
7.3 ANALYZER 65
7.3.1 BIO CHEMISTRY ANALYZERS 66
7.3.2 HAEMATOLOGY ANALYZERS 66
7.3.3 IMMUNO-BASED ANALYZERS 66
7.4 SOFTWARE & INFORMATICS 66
7.4.1 LABORATORY INFORMATION MANAGEMENT SYSTEM (LIMS) 67
7.4.2 ELECTRONIC LABORATORY NOTEBOOK (ELN) 67
7.4.3 LABORATORY EXECUTION SYSTEMS (LES) 67
7.4.4 SCIENTIFIC DATA MANAGEMENT SYSTEMS (SDMS) 68
8 ASIA PACIFIC LAB AUTOMATION MARKET, BY AUTOMATION TYPE 69
8.1 OVERVIEW 70
8.2 TOTAL LAB AUTOMATION 73
8.3 MODULAR AUTOMATION 73
9 ASIA PACIFIC LAB AUTOMATION MARKET, BY APPLICATION 74
9.1 OVERVIEW 75
9.2 CLINICAL DIAGNOSTICS 78
9.3 DRUG DISCOVERY 78
9.4 GENOMICS SOLUTIONS 78
9.5 PROTEOMIC SOLUTIONS 79
9.6 ANALYTICAL CHEMISTRY 79
9.7 PROTEIN ENGINEERING 80
9.8 BIO ANALYSIS 80
9.9 SYSTEM BIOLOGY 81
9.10 OTHERS 81
10 ASIA PACIFIC LAB AUTOMATION MARKET, BY END USER 83
10.1 OVERVIEW 84
10.2 BIOTECHNOLOGY & PHARMACEUTICALS 87
10.3 HOSPITALS & LABORATORIES 87
10.4 RESEARCH & ACADEMIC INSTITUTES 87
10.5 OTHERS 88
11 ASIA PACIFIC LAB AUTOMATION MARKET, BY REGION 89
11.1 ASIA-PACIFIC 90
11.1.1 CHINA 98
11.1.2 JAPAN 102
11.1.3 SOUTH KOREA 106
11.1.4 INDIA 110
11.1.5 AUSTRALIA 114
11.1.6 SINGAPORE 118
11.1.7 THAILAND 122
11.1.8 MALAYSIA 126
11.1.9 INDONESIA 130
11.1.10 PHILIPPINES 134
11.1.11 REST OF ASIA-PACIFIC 138
12 ASIA PACIFIC LAB AUTOMATION MARKET: COMPANY LANDSCAPE 139
12.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 139
13 SWOT ANALYSIS 140
14 COMPANY PROFILE 141
14.1 THERMO FISHER SCIENTIFIC INC. 141
14.1.1 COMPANY SNAPSHOT 141
14.1.2 REVENUE ANALYSIS 142
14.1.3 COMPANY SHARE ANALYSIS 142
14.1.4 PRODUCT PORTFOLIO 142
14.1.5 RECENT DEVELOPMENTS 143
14.2 DANAHER 144
14.2.1 COMPANY SNAPSHOT 144
14.2.2 REVENUE ANALYSIS 144
14.2.3 COMPANY SHARE ANALYSIS 145
14.2.4 PRODUCT PORTFOLIO 145
14.2.5 RECENT DEVELOPMENTS 145
14.3 F. HOFFMANN- LA ROCHE LTD 146
14.3.1 COMPANY SNAPSHOT 146
14.3.2 REVENUE ANALYSIS 146
14.3.3 COMPANY SHARE ANALYSIS 147
14.3.4 PRODUCT PORTFOLIO 147
14.3.5 RECENT DEVELOPMENTS 147
14.4 PERKINELMER INC 149
14.4.1 COMPANY SNAPSHOT 149
14.4.2 REVENUE ANALYSIS 150
14.4.3 COMPANY SHARE ANALYSIS 150
14.4.4 PRODUCT PORTFOLIO 151
14.4.5 RECENT DEVELOPMENTS 151
14.5 BD 152
14.5.1 COMPANY SNAPSHOT 152
14.5.2 REVENUE ANALYSIS 152
14.5.3 COMPANY SHARE ANALYSIS 153
14.5.4 PRODUCT PORTFOLIO 153
14.5.5 RECENT DEVELOPMENTS 153
14.6 ABBOTT 154
14.6.1 COMPANY SNAPSHOT 154
14.6.2 REVENUE ANALYSIS 154
14.6.3 PRODUCT PORTFOLIO 155
14.6.3 RECENT DEVELOPMENTS 155
14.7 AGILENT TECHNOLOGIES 156
14.7.1 COMPANY SNAPSHOT 156
14.7.2 REVENUE ANALYSIS 156
14.7.3 PRODUCT PORTFOLIO 157
14.7.4 RECENT DEVELOPMENTS 157
14.8 AURORA BIOMED INC. 158
14.8.1 COMPANY SNAPSHOT 158
14.8.2 PRODUCT PORTFOLIO 158
14.8.3 RECENT DEVELOPMENTS 158
14.9 AZENTA US INC 159
14.9.1 COMPANY SNAPSHOT 159
14.9.2 REVENUE ANALYSIS 159
14.9.3 PRODUCT PORTFOLIO 160
14.9.4 RECENT DEVELOPMENTS 160
14.10 BIOMERIEUX 161
14.10.1 COMPANY SNAPSHOT 161
14.10.2 REVENUE ANALYSIS 161
14.10.3 PRODUCT PORTFOLIO 162
14.10.4 RECENT DEVELOPMENTS 162
14.11 EPPENDORF SE 163
14.11.1 COMPANY SNAPSHOT 163
14.11.2 PRODUCT PORTFOLIO 163
14.11.3 RECENT DEVELOPMENTS 163
14.12 HAMILTON COMPANY 164
14.12.1 COMPANY SNAPSHOT 164
14.12.2 PRODUCT PORTFOLIO 164
14.12.3 RECENT DEVELOPMENTS 164
14.13 HUDSON ROBOTICS 165
14.13.1 COMPANY SNAPSHOT 165
14.13.2 PRODUCT PORTFOLIO 165
14.13.3 RECENT DEVELOPMENTS 165
14.14 LABLYNX LIMS 166
14.14.1 COMPANY SNAPSHOT 166
14.14.2 PRODUCT PORTFOLIO 166
14.14.3 RECENT DEVELOPMENTS 166
14.15 LABVANTAGE SOLUTIONS INC. 167
14.15.1 COMPANY SNAPSHOT 167
14.15.2 PRODUCT PORTFOLIO 167
14.15.3 RECENT DEVELOPMENTS 167
14.16 LABWARE 168
14.16.1 COMPANY SNAPSHOT 168
14.16.2 PRODUCT PORTFOLIO 168
14.16.3 RECENT DEVELOPMENTS 168
14.17 QIAGEN 169
14.17.1 COMPANY SNAPSHOT 169
14.17.2 REVENUE ANALYSIS 169
14.17.3 PRODUCT PORTFOLIO 170
14.17.4 RECENT DEVELOPMENTS 170
14.18 SIEMENS HEALTHCARE GMBH 172
14.18.1 COMPANY SNAPSHOT 172
14.18.2 REVENUE ANALYSIS 172
14.18.3 PRODUCT PORTFOLIO 173
14.18.4 RECENT DEVELOPMENTS 173
14.19 TECAN TRADING AG 174
14.19.1 COMPANY SNAPSHOT 174
14.19.2 REVENUE ANALYSIS 174
14.19.3 PRODUCT PORTFOLIO 175
14.19.4 RECENT DEVELOPMENTS 175
15 QUESTIONNAIRE 176
16 RELATED REPORTS 179